José Jiménez Flores

4PUBLICATIONS
61CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 13, 2026
Application of a translational research platform to unveil efficacy signals and mechanisms of resistance of FGFR inhibitors in multiple FGFR-altered solid tumors.

|Dec 16, 2025
Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy.

Elena Garralda, Charles Abbott, Alma Calahorro

|Dec 08, 2022
Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response.

Nikaoly Ciriaco, Esther Zamora, Santiago Escrivá-de-Romaní

|Apr 28, 2022
High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.

Joan Frigola, Caterina Carbonell, Patricia Irazno

Pageof 1

Frequent Collaborators

2 joint publications

Elena Garralda

2 joint publications

Paolo Nuciforo

2 joint publications

Josep Tabernero

2 joint publications

Rodrigo Dienstmann